CADRE HOLDINGS CDRE 深 沪
已收盘 08-01 16:00:00 美东时间
32.34
-0.635
-1.93%
华盛通- 最 高32.71
- 今 开32.44
- 成交量 28.62万股
- 最 低 31.92
- 昨 收 32.975
- 总市值 13.15亿
- 52周最高 40.05
- 市盈率 静 36.10
- 换手率 0.70%
- 52周最低 26.9793
- 委 比 99.00%
- 总股本 4065.96万
- 历史最高 40.05
- 量 比 1.37
- 振 幅 2.40%
- 历史最低 12.90
- 每 手 1
- 风险率 2.69%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Cadre Holdings declares $0.095 dividend
Cadre Holdings (NYSE:CDRE) declares $0.095/share quarterly dividend, in line with previous. Forward yield 1.16% Payable Aug. 15; for shareholders of record Aug. 1; ex-div Aug. 1. See CDRE Dividend Sco...
07-23 04:18
美股大行评级 | 潜在涨幅290.69%！乌龙制药获丰业银行升目标价至47美元，维持"跑赢大市"评级
<span> <meta content="no-referrer" name="referrer"></span><p>https://static-hk.hstong.com/public/forum-v2/status/icon/50267976/originalpic/1140565699993591809.png</p><span style="color:#999999;">编者按：每日追踪华尔街最新评级与目标价，挖掘潜力股投资机会。</span><blockquote> <p><span style="color:#fa1432;"><strong>今日重点评级关注</strong></span></p></blockquote><p>• 丰业银行：维持乌龙制药(URGN)"跑赢大市"评级，目标价从23美元升至47美元</p> <p>• Guggenheim：维持ADC Therapeutics(ADCT)"买入"评级，目标价从7美元升至10美元</p>
06-16 08:40
B of A Securities Downgrades Cadre Hldgs to Neutral, Lowers Price Target to $38
B of A Securities analyst Ronald Epstein downgrades Cadre Hldgs (NYSE:CDRE) from Buy to Neutral and lowers the price target from $45 to $38.
06-13 22:03
Cadre Holdings shares are trading higher after the company reported better-than-expected Q1 financial results and issued FY25 sales guidance above estimates.
Cadre Holdings shares are trading higher after the company reported better-than...
05-07 23:08
Cadre Holdings Solidifies Executive Leadership with New Agreements
Cadre Holdings ( ($CDRE) ) just unveiled an announcement. On January 24, 2025, ...
01-28 05:50
Cadre Holdings raises quarterly dividend by b8.6% to $0.095/share
Cadre Holdings (NYSE:CDRE) declares $0.095/share quarterly dividend, 8.6% increase from prior dividend of $0.087. Forward yield 0.98% Payable Feb. 14; for shareholders of record Jan. 31; ex-div Jan. 3...
01-22 05:21
Cadre to acquire multiple nuclear brands from Carr’s Group
Cadre Holdings (NYSE:CDRE) on Thursday said that it has entered into a definitive agreement to acquire Carr's Engineering (excluding Chirton Engineering) and Carr's Engineering (US) for an enterprise ...
01-16 16:09
Cadre Holdings Reports Resilient Q3 2024 Performance
Cadre Holdings, Inc. ( ($CDRE) ) has released its Q3 earnings. Here is a breakd...
2024-11-07 12:59
Jim Cramer: Viking Therapeutics Has 'Many Ships Coming In'
Viking Therapeutics received an Overweight rating and a December 2025 price target of $80 from JPMorgan analysts.
2024-09-20 20:46
Don't Ignore The Insider Selling In Cadre Holdings
We wouldn't blame Cadre Holdings, Inc. (NYSE:CDRE) shareholders if they were a ...
2024-08-19 18:11
